Go Back

Morris Levin

Morris Levin

Institution: UCSF Headache Center, San Francisco
Country: USA

Biography

Dr Levin is a Professor in the University of California San Francisco Department of Neurology, and is the Director of the UCSF Headache Center.  He is board certified in Neurology (ABPN), Pain Medicine (ABPN), and Headache Medicine (UCNS).

He has authored medical journal articles and textbook chapters, as well as texts, most recently including Comprehensive Review of Headache Medicine 2nd Ed. (Oxford University Press 2025), Headache and Facial Pain (Oxford University Press 2022), Emergency Neurology (Oxford University Press 2022), and “Understanding Your Migraines”, a guide for patients and families (Oxford University Press 2017). He also co-authored the International Classification of Headache Disorders (ICHD) 3rd edition.

Dr Levin currently serves on the Board of Trustees of the International Headache Society (IHS), and the Board of Directors of the Headache Cooperative of the Pacific.  Dr Levin is the director of the UCSF Headache Medicine Fellowship training program.

Disclosures

Employment: None

Leadership or Board position in other society: Board of Directors member Headache Cooperative of the Pacific

Professional membership: American Headache Society, American Academy of Neurology

Headache Cooperative of the Pacific

Personal fees (in the last three years): Consulting fees for one-time consultations: Slingshot, Soleil Labs, KQ Health / Consulting fees for one-time advisory boards: AbbVie, Amneal, Axsome, Linpharma, Vectura / Consulting for one-time production of education material: Lilly

Research support: None

Royalties or licenses: Oxford University Press, Anadem Publishing

Expert testimony: Occasional consulting with attorneys and providing testimony for medicolegal cases

Principal investigator: None

Relationship with scientific journals: None

Reviewer for Headache, Cephalalgia, Neurology, Journal of Neurology, Neurosurgery and Psychiatry, Annals of Neurology, JAMA Neurology

Commercial interests: None